Vinpocetine 10 mg Ingredients & Drug Interactions
by Source Naturals
What is this page for?
First and foremost: checking Vinpocetine 10 mg against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Vinpocetine 10 mg is a dietary supplement by Source Naturals with 1 active ingredient. Its ingredients are commonly taken for memory and cognitive support, brain blood flow, stroke recovery.Based on those ingredients, 208 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Vinpocetine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Vinpocetine 10 mg by Source Naturals
Ask about any prescription or over-the-counter medication and we check it for interactions with Vinpocetine 10 mg by Source Naturals — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Vinpocetine 10 mg by Source Naturals
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This product contains one active ingredient: vinpocetine, a compound that's been studied for its effects on blood flow and cognitive function. The tablet also includes microcrystalline cellulose, stearic acid, and magnesium stearate as inactive binders and fillers to hold it together.
Does it work?
Moderate evidence
The evidence for vinpocetine is mixed and depends on what you're taking it for. For dementia, the research suggests it's possibly effective — meaning there's some evidence it may help, but it's not definitive.
For tinnitus, motion sickness, stroke recovery, and chronic fatigue syndrome, we don't have enough reliable evidence in our data to say whether it works or not.
How safe is it?
Well-documented data
Vinpocetine appears to be generally well tolerated over the short term, but long-term safety data and supplement quality standards aren't well established. The most common side effects reported with oral use are anxiety, dizziness, headache, flushing, stomach discomfort, sleep problems, and hives.
Rare but serious effects include very low white blood cell counts (agranulocytosis), heart rhythm problems (arrhythmias), and seizures. Heart-related effects like changes in heart rate, blood pressure swings, palpitations, and atrial fibrillation have also been reported in clinical trials.
The FDA has advised against vinpocetine during pregnancy because safety data suggests it may be unsafe. If you're breastfeeding, there isn't enough safety information to recommend it — talk with your doctor or pharmacist about whether it's right for you.
Meds to double-check
Moderate interaction found
Before you take this, check with your doctor or pharmacist if you're on anticoagulant or antiplatelet drugs — blood thinners like warfarin, aspirin, clopidogrel, or dabigatran (Moderate severity). Also flag any medications that your liver processes through the CYP2C9 pathway, as vinpocetine may theoretically raise their levels (Moderate severity).
Your pharmacist can run your medication list through the tool on this page to be sure.
The bottom line
Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
Vinpocetine may be worth considering if you're interested in possible cognitive support and your doctor agrees — evidence for dementia is modest. However, it's not for you if you take blood thinners like warfarin or other anticoagulants, or if you're pregnant or breastfeeding.
Check your complete medication list with your pharmacist or doctor before starting, especially if you're on any blood-thinning drugs or take medications processed by your liver.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Jan 23, 2023.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Vinpocetine 10 mg, straight from the product label.
| Brand | Source Naturals |
|---|---|
| Barcode (UPC) | 021078013990 |
| Net contents | 120 Tablet(s) |
| Market status | On market |
| Date entered into DSLD | Jan 23, 2023 |
| DSLD ID | 273139 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Tablet Or Pill |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Vegetarian, Adult (18 - 50 Years), Women (not pregnant or lactating), Gluten Free, Dairy Free, Sugar Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Vinpocetine 10 mg by Source Naturals, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Vinpocetine | 10 mg | -- |
Other ingredients: Microcrystalline Cellulose, Stearic Acid, Magnesium Stearate
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
FDA Statement of Identity
Dietary Supplement
Formulation
Supports cognitive performance
Non GMO Validated
Suitable for Vegetarians.
Contains no yeast, dairy, egg, gluten, corn, soy or wheat. Contains no sugar, starch, salt, preservatives, or artificial color, flavor or fragrance.
Seals/Symbols
Non GMO Validated
Formula
Research suggests that vinpocetine may help to support healthy cognitive performance. Preliminary studies have shown that vinpocetine supports healthy cerebral blood flow.
Suggested/Recommended/Usage/Directions
Directed Use: 1 tablet 1 to 3 times daily with food. Do not exceed three tablets per day.
Precautions
Do not use if either tamper-evident seal is broken or missing.
Keep out of the reach of children.
Warning: May cause stomach upset if taken on an empty stomach. If you have low blood pressure, have a history of heart problems, strokes or are using blood-thinning medications, consult your doctor before using this product.
If you have low blood pressure, have a history of heart problems, strokes or are using bloodthinning medications, consult your doctor before using this product.
For adult use only.
Do not use if you are pregnant, may become pregnant, or breastfeeding.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Brand IP Statement(s)
Copyright SOURCE NATURALS, INC.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Vinpocetine 10 mg by Source Naturals label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Vinpocetine 10 mg by Source Naturals
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size1 Tablet(s) Dosage formTablet Or Pill Servings per container120 Amounts shown are per serving.
Vinpocetine
Interacts with208 drugs
Vinpocetine is a lab-made compound based on a chemical from the periwinkle plant, and it is marketed mainly for memory and brain health. The evidence...
Vinpocetine monograph & interactionsOther (inactive) ingredients: Microcrystalline Cellulose, Stearic Acid, Magnesium Stearate. These complete the product’s ingredient list but are not active constituents.
Vinpocetine 10 mg by Source Naturals Drug Interactions
HelloPharmacist Interaction Report
Source Naturals Vinpocetine 10 mg contains one active ingredient — vinpocetine — that interacts with blood thinners and related drugs.
The most serious concern is with anticoagulant and antiplatelet medications (Moderate severity): vinpocetine thins the blood by reducing red blood cell clumping and blood thickness, which raises your bleeding risk when combined with these drugs.
Read the full breakdown — every affected drug type, severity by severity
Vinpocetine also affects drugs broken down by the enzyme CYP2C9 (Moderate severity) — it may theoretically raise their levels in your body, though this hasn't been proven in human studies yet. Additionally, there's a Minor-severity interaction with warfarin specifically, where the combination slightly increases bleeding markers, though the changes were small in clinical trials.
Altogether, these interactions span 208 individual medications. Use the interaction checker below with your exact medications before you start.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Vinpocetine 10 mg?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Vinpocetine 10 mg interact with 208 drugs. Click any drug to see the details.
1 of the 1 ingredient in Vinpocetine 10 mg interact with drugs. Each result below shows which ingredient is responsible. Vinpocetine
Budesonide, FormoterolSymbicort
How Budesonide, Formoterol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Budesonide, Formoterol interactionBupivacaine, MeloxicamZynrelef Kit
How Bupivacaine, Meloxicam interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Bupivacaine, Meloxicam interactionCabliviCablivi
How Cablivi interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Cablivi interactionCangrelorKengreal
How Cangrelor interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Cangrelor interactionCarvedilolCoreg, Coreg CR
How Carvedilol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Carvedilol interactionCelecoxibCelebrex, Elyxyb
How Celecoxib interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Celecoxib interactionCelecoxib, TramadolSeglentis
How Celecoxib, Tramadol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Celecoxib, Tramadol interactionCilostazolPletal
How Cilostazol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Cilostazol interactionClomipramineAnafranil, Anafranil SR
How Clomipramine interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Clomipramine interactionClopidogrelPlavix
How Clopidogrel interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Clopidogrel interactionDalteparinFragmin
How Dalteparin interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Dalteparin interactionDanaparoidOrgaran
How Danaparoid interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Danaparoid interactionDefibrotide SodiumDefitelio
How Defibrotide Sodium interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Defibrotide Sodium interactionDesogestrel, Ethinyl EstradiolDesogen, Marvelon, Marvelon 21, Marvelon 28, Mircette, Ortho-Cept +2 more
How Desogestrel, Ethinyl Estradiol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Desogestrel, Ethinyl Estradiol interactionDiazepamDiastat AcuDial, Valium, Valium injection, Valtoco
How Diazepam interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diazepam interactionDiclofenacZorvolex
How Diclofenac interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diclofenac interactionDiclofenac PotassiumCambia, Cataflam, Cataflam IR, Voltaren Rapide, Voltarol Rapid
How Diclofenac Potassium interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diclofenac Potassium interactionDiclofenac SodiumAcoflam, Acoflam 75 SR, Acoflam Retard, Defenac, Defenac Retard, Defenac SR +40 more
How Diclofenac Sodium interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diclofenac Sodium interactionDiclofenac Sodium, MisoprostolArthrotec 50, Arthrotec 75
How Diclofenac Sodium, Misoprostol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diclofenac Sodium, Misoprostol interactionDiclofenac EpolamineFlector, Licart
How Diclofenac Epolamine interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diclofenac Epolamine interactionDicumarolDicumarol
How Dicumarol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Dicumarol interactionDiphenhydramine Hydrochloride, Naproxen SodiumAleve PM
How Diphenhydramine Hydrochloride, Naproxen Sodium interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Diphenhydramine Hydrochloride, Naproxen Sodium interactionDipyridamoleDipyridamole, Persantin, Persantin Injection, Persantin Retard, Persantine
How Dipyridamole interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Dipyridamole interactionDronabinolMarinol, Syndros
How Dronabinol interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Dronabinol interactionEdoxabanSavaysa
How Edoxaban interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Edoxaban interactionEffientPrasugrel
How Effient interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Effient interactionEnasidenibIdhifa
How Enasidenib interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Enasidenib interactionEnoxaparinLovenox
How Enoxaparin interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Enoxaparin interactionEptifibatideIntegrilin
How Eptifibatide interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Eptifibatide interactionErdafitinibBalversa
How Erdafitinib interacts with Vinpocetine 10 mg — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Erdafitinib interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Vinpocetine 10 mg with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Vinpocetine
Anticoagulant/Antiplatelet Drugs
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Clinical research shows that vinpocetine decreases red blood cell aggregation, as well as plasma and whole blood viscosity. This effect has been seen with intravenous vinpocetine 1 mg/kg and oral vinpocetine 30 mg daily. Vinpocetine also seems to have antiplatelet effects.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
In vitro research shows that vinpocetine weakly inhibits CYP2C9. However, this effect has not been reported in humans.
Warfarin (Coumadin)
Vinpocetine might modestly increase the risk of bleeding when taken with warfarin.
Clinical research shows that the combination of warfarin and vinpocetine leads to slight increases in prothrombin time and the area under the concentration curve for warfarin. However, these increases were small, and researchers suggest that this interaction is not likely to be clinically significant in most patients.
Brand information
Manufacturer and brand details for Vinpocetine 10 mg, from the product label.
Source Naturals
- Name
- Source Naturals, Inc.
- Street Address
- P. O. Box 2118
- City
- Santa Cruz
- State
- CA
- ZipCode
- 95062
- Web Address
- www.sourcenaturals.com
Vinpocetine 10 mg by Source Naturals: Common Questions
Does Vinpocetine 10 mg by Source Naturals interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take this if I'm on warfarin or another blood thinner?
Is vinpocetine safe to take while pregnant?
Can I take this while breastfeeding?
What does vinpocetine actually do?
What are the most common side effects?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Vinpocetine 10 mg is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Vinpocetine 10 mg’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
Vinpocetine 10 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 27 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Vinpocetine 27 references
- Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31-43. PubMed
- Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425-30. PubMed
- Akopov SE, Gabrielian ES. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. Eur J Clin Pharmacol 1992;42:257-9. PubMed
- Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999;4:144-61..
- Wollschlaeger B. Efficacy of vinpocetine in the management of cognitive impairment and memory loss. JANA 2001;4:25-30.
- Hitzenberger G, Sommer W, Grandt R. Influence of vinpocetine on warfarin-induced inhibition of coagulation. Int J Clin Pharmacol Ther Toxicol 1990;28:323-8..
- Dekoninck, W. J., Jocquet, P., Jacquy, J., and Henriet, M. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneimittelforschung. 1978;28(9):1654-1657.
- Fischhof, P. K., Moslinger-Gehmayr, R., Herrmann, W. M., Friedmann, A., and Russmann, D. L. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34(1):29-35. PubMed
- Feher, G., Koltai, K., Kesmarky, G., Horvath, B., Toth, K., Komoly, S., and Szapary, L. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine. 2009;16(2-3):111-117. PubMed
- Kuzuya, F. Effects of vinpocetine on platelet aggregability and erythrocyte deformability. Ther Hung. 1985;33(1):22-34.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Osawa, M. and Maruyama, S. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Ther.Hung. 1985;33(1):7-12.
- Ebi, O. Open-labeled phase III clinical trials with vinpocetine in Japan. Ther.Hung. 1985;33(1):41-49.
- Richichi, I., Valsecchi, O., Falcone, C., Sofi, A., and Zanini, L. [A case of "torsade de pointe" during vincamine therapy]. Minerva Cardioangiol. 1978;26(3):197-200.
- Dany, F., Merle, L., Goudoud, J. C., Liozon, F., Blanc, P., Bouvot, J. C., Nicot, G., and Dangoumau, J. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)]. Therapie
- Fenzl, E., Apecechea, M., Schaltenbr, R., and Fridel, R. Long term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome. Senile dementia: early detection 1986;580-585.
- Peruzza, M. and DeJacobis, M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. ADV THER 1986;3(4):201-209.
- Manconi, E., Binaghi, F., and Pitzus, F. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. CURR THER RES, CLIN EXP 1986;40(4):702-709.
- Blaha, L., Erzigkeit, H. L., Adamczyk, L. A., Freytag, L. S., and Schaltenbrand, R. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology: Clinical & Experimental 1989;4(2):103-111. DOI
- Shimizu, Y., Saitoh, K., Nakayama, M., Suto, K., Daikohara, R., and Nemoto, T. Agranulocytosis induced by vinpocetine. Medicine On-line 2011;
- Kong L, Song C, Ye L, et al. The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method. Evid Based Complement Alternat Med. 2016;2016:5017135. PubMed
- Vinpocetine in Dietary Supplements. FDA Food/Dietary Supplements/Products & Ingredients. Available at: http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm518478.htm. Accessed 6 September 2016.
- Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine. FDA Food/Dietary Supplements/Products & Ingredients. Available at: https://www.fda.gov/news-events/press-announcements/statement-
- Zhang W, Huang Y, Li Y, et al. Efficacy and safety of vinpocetine as part of treatment for acute cerebral infarction: A randomized, open-label, controlled, multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) trial. Clin Drug Investig 2016; PubMed
- National Toxicology Program. NTP technical report on the prenatal development toxicity studies of vinpocetine (CAS No. 42971-09-5) in Sprague Dawley Rats and New Zealand White Rabbits (Gavage Studies). Research Triangle Park, NC: National Toxicology Progr
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci PubMed
- Hu X, Guo K, Li J, et al. Postoperative ecchymoma of eyelid after botulinum toxin injection for hemifacial spasm: a case report. Front Neurol 2023;14:1171303. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC